JP2013530236A5 - - Google Patents

Download PDF

Info

Publication number
JP2013530236A5
JP2013530236A5 JP2013518683A JP2013518683A JP2013530236A5 JP 2013530236 A5 JP2013530236 A5 JP 2013530236A5 JP 2013518683 A JP2013518683 A JP 2013518683A JP 2013518683 A JP2013518683 A JP 2013518683A JP 2013530236 A5 JP2013530236 A5 JP 2013530236A5
Authority
JP
Japan
Prior art keywords
alkyl
haloalkyl
halo
cyano
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2013518683A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013530236A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/042499 external-priority patent/WO2012003262A1/en
Publication of JP2013530236A publication Critical patent/JP2013530236A/ja
Publication of JP2013530236A5 publication Critical patent/JP2013530236A5/ja
Withdrawn legal-status Critical Current

Links

JP2013518683A 2010-07-01 2011-06-30 Pi3k活性の阻害剤としての複素環式化合物およびその用途 Withdrawn JP2013530236A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36074310P 2010-07-01 2010-07-01
US61/360,743 2010-07-01
PCT/US2011/042499 WO2012003262A1 (en) 2010-07-01 2011-06-30 Heterocyclic compounds and their use as inhibitors of pi3k activity

Publications (2)

Publication Number Publication Date
JP2013530236A JP2013530236A (ja) 2013-07-25
JP2013530236A5 true JP2013530236A5 (show.php) 2014-08-14

Family

ID=44304257

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013518683A Withdrawn JP2013530236A (ja) 2010-07-01 2011-06-30 Pi3k活性の阻害剤としての複素環式化合物およびその用途

Country Status (8)

Country Link
US (1) US8759371B2 (show.php)
EP (1) EP2588468B1 (show.php)
JP (1) JP2013530236A (show.php)
AU (1) AU2011271460B2 (show.php)
CA (1) CA2803259A1 (show.php)
ES (1) ES2472720T3 (show.php)
MX (1) MX2012014996A (show.php)
WO (1) WO2012003262A1 (show.php)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2448938T5 (en) 2009-06-29 2015-10-05 Incyte Corp Pyrimidinones AS PI3K inhibitors
US8759359B2 (en) 2009-12-18 2014-06-24 Incyte Corporation Substituted heteroaryl fused derivatives as PI3K inhibitors
AR081823A1 (es) 2010-04-14 2012-10-24 Incyte Corp DERIVADOS FUSIONADOS COMO INHIBIDORES DE PI3Kd
US9062055B2 (en) 2010-06-21 2015-06-23 Incyte Corporation Fused pyrrole derivatives as PI3K inhibitors
AR084366A1 (es) 2010-12-20 2013-05-08 Incyte Corp N-(1-(fenil sustituido)etil)-9h-purin-6-aminas como inhibidores de pi3k
WO2012125629A1 (en) 2011-03-14 2012-09-20 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
US9126948B2 (en) 2011-03-25 2015-09-08 Incyte Holdings Corporation Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
HRP20170285T1 (hr) 2011-09-02 2017-04-21 Incyte Holdings Corporation Heterociklilamini kao inhibitori pi3k
US20150011569A1 (en) * 2011-12-15 2015-01-08 Philadelphia Health & Education Corporation D/B/A Drexel University College Of Medicine NOVEL P13K p110 INHIBITORS AND METHODS OF USE THEREOF
AR090548A1 (es) 2012-04-02 2014-11-19 Incyte Corp Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
EP2916868B1 (en) 2012-11-08 2022-05-11 Rhizen Pharmaceuticals S.A. Pharmaceutical compositions containing a pde4 inhibitor and a pi3 delta or dual pi3 delta-gamma kinase inhibitor
US9908893B2 (en) 2013-06-11 2018-03-06 Latvian Institute Of Organic Synthesis Thieno [2,3-b] pyridines as multidrug resistance modulators
US10077277B2 (en) 2014-06-11 2018-09-18 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
JP6291601B2 (ja) 2014-07-04 2018-03-14 ルピン・リミテッド Pi3k阻害剤としてのキノリジノン誘導体
US9708272B2 (en) 2014-08-29 2017-07-18 Tes Pharma S.R.L. Inhibitors of α-amino-β-carboxymuconic acid semialdehyde decarboxylase
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
MX373232B (es) 2015-02-27 2020-05-08 Incyte Holdings Corp Sales del inhibidor fosfoinositida 3-cinasa (pi3k) y procesos para su preparación.
US9988401B2 (en) 2015-05-11 2018-06-05 Incyte Corporation Crystalline forms of a PI3K inhibitor
WO2016183060A1 (en) 2015-05-11 2016-11-17 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
TWI773657B (zh) 2015-12-18 2022-08-11 美商亞德利克斯公司 作爲非全身tgr5促效劑之經取代之4-苯基吡啶化合物
US12084472B2 (en) 2015-12-18 2024-09-10 Ardelyx, Inc. Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
US10919914B2 (en) 2016-06-08 2021-02-16 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
TW201813963A (zh) 2016-09-23 2018-04-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201815787A (zh) 2016-09-23 2018-05-01 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201825465A (zh) 2016-09-23 2018-07-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
MX2020012826A (es) 2018-06-01 2021-03-09 Incyte Corp Regimen de dosificacion para el tratamiento de trastornos relacionados con fosfatidilinositol 3-cinasas (pi3k).

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT72878B (en) 1980-04-24 1983-03-29 Merck & Co Inc Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents
DE3020458C2 (de) 1980-05-29 1986-07-31 Herzog, Thomas, Prof. Dr., 3500 Kassel Vorgehängte Fassaden-, Bau- oder Dekorationsplatte
US6043062A (en) 1995-02-17 2000-03-28 The Regents Of The University Of California Constitutively active phosphatidylinositol 3-kinase and uses thereof
GB9611460D0 (en) 1996-06-01 1996-08-07 Ludwig Inst Cancer Res Novel lipid kinase
US5858753A (en) 1996-11-25 1999-01-12 Icos Corporation Lipid kinase
US5822910A (en) 1997-10-02 1998-10-20 Shewmake; I. W. Fishing line tensioning device
ES2563458T3 (es) * 2007-03-23 2016-03-15 Amgen Inc. Compuestos heterocíclicos y sus usos
HRP20140147T1 (hr) * 2007-03-23 2014-03-28 Amgen Inc. 3-supstituirani derivati hinolina ili hinoksalina i njihova uporaba kao inhibitora fosfatidilinozitol 3-kinaze (pi3k)
JP5564947B2 (ja) 2007-09-26 2014-08-06 アステラス製薬株式会社 キノロン誘導体
JP5731978B2 (ja) * 2008-09-26 2015-06-10 インテリカイン, エルエルシー 複素環キナーゼ阻害剤
GB0821693D0 (en) 2008-11-27 2008-12-31 Ucb Pharma Sa Therapeutic agents
US8513284B2 (en) 2009-02-13 2013-08-20 Ucb Pharma, S.A. Fused pyridine and pyrazine derivatives as kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2013530236A5 (show.php)
JP2013533883A5 (show.php)
JP2013533884A5 (show.php)
JP2013530238A5 (show.php)
HRP20160350T1 (hr) Heterociklički spojevi i njihove uporabe
JP2011502994A5 (show.php)
RU2016143333A (ru) Амидные производные и их фармацевтически приемлемые соли, способ их получения и медицинское применение
JP2019532930A5 (show.php)
JP2018520161A5 (show.php)
JP2015527401A5 (show.php)
JP2017512833A5 (show.php)
JP2015535277A5 (show.php)
JP2019527230A5 (show.php)
JP2015143283A5 (show.php)
RU2014128307A (ru) Пиррольное производное шестичленного гетероарильного кольца, способ его получения и его медицинское применение
JP2017508816A5 (show.php)
JP2016510758A5 (show.php)
RU2018102365A (ru) Новые гидроксисложноэфирные производные, способ их получения и фармацевтические композиции, содержащие их
ME02754B (me) Ligandi opioidnih receptora i postupci njihove upotrebe i pripreme
RU2014110623A (ru) Пирролопиразиновые ингибиторы киназы
JP2013523614A5 (show.php)
JP2016518385A5 (show.php)
JP2010280669A5 (show.php)
JP2016537368A5 (show.php)
HRP20140147T1 (hr) 3-supstituirani derivati hinolina ili hinoksalina i njihova uporaba kao inhibitora fosfatidilinozitol 3-kinaze (pi3k)